Wynn Resorts, Limited (WYNN) Stock Price Today
South32 boosts copper output 11% in FY27 start with record $153M quarterly Chile payout
South32 Ltd began fiscal year 2027 with an 11% rise in copper production at its Sierra Gorda mine, driven by higher ore grades and ongoing expansion efforts including a new grinding line to increase capacity by 25%. The company also saw a 14% increas...
China's Q3 economic growth rises 4.5% driven by tech exports despite property slump
China's economy grew by 4.5% in the third quarter compared to the previous year. This growth was mainly fueled by strong foreign demand for Chinese technology products, which helped offset challenges from a declining property market and weak consumer...
Kingfisher Mining raises $2.25M to boost Copper Blow copper-gold exploration near Broken Hill.
Kingfisher Mining secured $2.25 million through a share placement at a 5.6% premium to fund expanded drilling and exploration at its Copper Blow Project near Broken Hill. Recent drilling showed promising copper-gold grades, with significant untested ...
Brunswick upgraded to soft buy as growth and AI investments boost outlook despite challenges
Brunswick Corporation has been upgraded to a soft 'buy' rating due to its attractive valuation amid macroeconomic challenges and recent share underperformance. The company's Propulsion and Engine P&A segments are driving strong growth through market ...
Tesla, Meta, and Netflix earnings highlight key investor focus this week amid mixed growth and profitability signals.
Tesla's Q3 earnings will be closely watched as deliveries beat forecasts but profitability remains uncertain due to potential pricing concessions and rising costs. Meta's shares have rallied 37% thanks to its AI product Muse, though high spending rai...
Disc Medicine to webcast APOLLO Phase 3 trial results of bitopertin for erythropoietic protoporphyria
Disc Medicine announced a webcast on October 19, 2026, to discuss topline results from its APOLLO Phase 3 trial of bitopertin, an investigational oral drug for erythropoietic protoporphyria (EPP). Bitopertin targets glycine transporter 1 to modulate ...
Actinogen Medical nears key Alzheimer's trial results with strong cash position of A$21.9M.
Actinogen Medical completed the main phase of its XanaMIA Phase 2b/3 Alzheimer's trial, with topline results expected in November. The trial tests Xanamem 10 mg daily in mild to moderate Alzheimer's patients, focusing on cognitive outcomes. The compa...
AI's growing power demand may worsen, with Elon Musk planning orbital AI data centers powered by solar energy.
Tech analyst James Altucher draws a parallel between the 1865 coal consumption surge and AI's increasing power needs, despite efficiency gains. He highlights Elon Musk's unique strategy of vertical integration, including plans to build AI data center...
FFR to hold Nasdaq listing ceremony Oct 26, launches affordable humanoid robots and new AI education programs
FFR will host its Nasdaq listing ceremony and first Investor Day on October 26 in New York, unveiling its strategy and business plans. The company launched two new affordable Embodied AI humanoid robots: FF Nova priced under $2,500 and Nova Mini at $...
Tesla criticized for ignoring lucrative robotaxi and robotics markets, stock seen as overpriced at 163x 2027 EPS.
Stone Fox Capital criticizes Tesla for focusing on flashy tech like the Roadster 'flying car' instead of scaling robotaxi and humanoid robot businesses that could tap into markets worth over $1 trillion. Tesla's Cybercab and Optimus projects are not ...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.